Theoretical and practical considerations concerning the use of NMDA antagonists in the treatment of the epilepsies.
Porter
R J
RJ
Office of the Director, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD.
Rogawski
M A
MA
D000818:Animals; D004827:Epilepsy / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors*
D016194:Receptors, N-Methyl-D-Aspartate